@prefix this: <http://purl.org/np/RAGc14iFnn-sVIUbLdGjH4hGqYzvg6bOcrmODXabDFADs> .
@prefix sub: <http://purl.org/np/RAGc14iFnn-sVIUbLdGjH4hGqYzvg6bOcrmODXabDFADs#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix orcid: <https://orcid.org/> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix eco: <http://purl.obolibrary.org/obo/ECO_> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:association rdf:object <https://identifiers.org/MONDO:0001158>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/CHEBI:5118>;
    rdfs:label "Fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD)";
    bl:association_type bl:ChemicalToGeneAssociation;
    bl:has_evidence sub:targetgroup;
    bl:provided_by "DailyMed";
    bl:relation <http://purl.obolibrary.org/obo/RO_0002606>;
    bl:stage_qualifier sub:lifeStage .
  
  sub:lifeStage a bl:LifeStage;
    rdfs:label "7 to 17 years" .
  
  sub:targetgroup a eco:0000180;
    bl:category bl:EvidenceType;
    bl:has_drug <https://identifiers.org/CHEBI:5118>;
    bl:has_phenotype <https://identifiers.org/MONDO:0001158> .
  
  <https://identifiers.org/CHEBI:5118> bl:category bl:Drug .
  
  <https://identifiers.org/MONDO:0001158> bl:category bl:Disease .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1501-1082 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB";
    npx:hasSignature "XzikHlY0K82nW8dmPm0oEwFjorjH+bitfb58Gpv6DY50FFnwnEkq578kBHk0Ds0mMd75w89zZTTfX5ojkPpfzVE+wGGTG9diu9IwBERGHxvRFx8gnuWfgHk0ar7L42RuurV+DZHoZnUvlO836aG15Ys0gAWZjoePX3uSqHSlDIk=";
    npx:hasSignatureTarget this: .
  
  this: dct:created "2020-12-01T10:21:48.162+01:00"^^xsd:dateTime;
    dct:creator orcid:0000-0002-1501-1082;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA8AXz5jnk5caKG-RnOT39_RD_WmPG4chQc2cBoiIzQ_U> .
}